BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19073243)

  • 1. Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
    Werle M; Takeuchi H
    Int J Pharm; 2009 Mar; 370(1-2):26-32. PubMed ID: 19073243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
    Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
    Takeuchi H; Matsui Y; Yamamoto H; Kawashima Y
    J Control Release; 2003 Jan; 86(2-3):235-42. PubMed ID: 12526820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems.
    Takeuchi H; Thongborisute J; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Adv Drug Deliv Rev; 2005 Nov; 57(11):1583-94. PubMed ID: 16169120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro uptake of lysozyme-loaded liposomes coated with chitosan biopolymer as model immunoadjuvants.
    Madrigal-Carballo S; Vila AO; Sibaja M; Reed JD; Molina F
    J Liposome Res; 2010 Mar; 20(1):1-8. PubMed ID: 19514859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmucosal macromolecular drug delivery.
    Prego C; García M; Torres D; Alonso MJ
    J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
    Huang A; Makhlof A; Ping Q; Tozuka Y; Takeuchi H
    Drug Deliv; 2011 Nov; 18(8):562-9. PubMed ID: 21823926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.
    Amin M; Jaafari MR; Tafaghodi M
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):225-9. PubMed ID: 19699067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery.
    Thongborisute J; Takeuchi H; Yamamoto H; Kawashima Y
    Pharmazie; 2006 Feb; 61(2):106-11. PubMed ID: 16526556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-coated liposomes for delivery to lungs by nebulisation.
    Zaru M; Manca ML; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
    Wu ZH; Ping QN; Wei Y; Lai JM
    Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of chitosan-coated liposomes for sustained delivery of tamarind fruit pulp's extract to the skin.
    Phetdee M; Polnok A; Viyoch J
    Int J Cosmet Sci; 2008 Aug; 30(4):285-95. PubMed ID: 18713075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F; Shin HJ; Lee BJ; Han HK
    Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization.
    Manconi M; Mura S; Manca ML; Fadda AM; Dolz M; Hernandez MJ; Casanovas A; Díez-Sales O
    Int J Pharm; 2010 Jun; 392(1-2):92-100. PubMed ID: 20338230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
    Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
    Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery.
    Luppi B; Bigucci F; Mercolini L; Musenga A; Sorrenti M; Catenacci L; Zecchi V
    J Pharm Pharmacol; 2009 Feb; 61(2):151-7. PubMed ID: 19178761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.
    Refai H; Hassan D; Abdelmonem R
    Drug Deliv; 2017 Nov; 24(1):278-288. PubMed ID: 28165805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of a chitosan-aprotinin conjugate for the peroral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation.
    Werle M; Loretz B; Entstrasser D; Föger F
    J Drug Target; 2007 Jun; 15(5):327-33. PubMed ID: 17541841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.